Lexicon Pharmaceuticals (LXRX) Short Interest Ratio & Short Volume → Do This Before July 30 2024 To Claim Trump’s Gift (From Wealthpin Pro) (Ad) Free LXRX Stock Alerts $1.76 +0.07 (+3.82%) (As of 09:46 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Lexicon Pharmaceuticals Short Interest DataCurrent Short Interest23,270,000 sharesPrevious Short Interest23,440,000 sharesChange Vs. Previous Month-0.73%Dollar Volume Sold Short$45.14 millionShort Interest Ratio6.3 Days to CoverLast Record DateMay 15, 2024Outstanding Shares246,240,000 sharesPercentage of Shares Shorted9.45%Today's Trading Volume152,422 sharesAverage Trading Volume3,909,506 sharesToday's Volume Vs. Average4% Short Selling Lexicon Pharmaceuticals ? Sign up to receive the latest short interest report for Lexicon Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLXRX Short Interest Over TimeLXRX Days to Cover Over TimeLXRX Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now Lexicon Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202423,270,000 shares $45.14 million -0.7%N/A6.3 $1.94 4/30/202423,440,000 shares $36.10 million +16.5%N/A5.3 $1.54 4/15/202420,120,000 shares $37.62 million -8.2%N/A4.2 $1.87 3/31/202421,910,000 shares $52.58 million +2.6%N/A4.7 $2.40 3/15/202421,350,000 shares $55.51 million +1.3%N/A4.6 $2.60 2/29/202421,070,000 shares $52.46 million -10.0%N/A4.9 $2.49 Get the Latest News and Ratings for LXRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lexicon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/15/202423,410,000 shares $83.81 million +1.7%N/A6.4 $3.58 1/31/202423,030,000 shares $43.07 million -8.9%N/A8 $1.87 1/15/202425,270,000 shares $34.62 million +8.8%N/A10.3 $1.37 12/31/202323,220,000 shares $35.53 million -0.3%N/A8.6 $1.53 12/15/202323,280,000 shares $29.57 million -0.5%N/A9.1 $1.27 11/30/202323,400,000 shares $24.80 million +4.6%N/A9.3 $1.06 11/15/202322,370,000 shares $25.50 million +1.8%N/A9.3 $1.14 10/31/202321,980,000 shares $27.26 million +12.7%N/A9.9 $1.24 10/15/202319,500,000 shares $23.21 million -3.7%N/A9.1 $1.19 9/30/202320,240,000 shares $22.06 million +7.1%N/A11.2 $1.09 9/15/202318,900,000 shares $26.46 million +6.1%N/A11.5 $1.40 8/31/202317,810,000 shares $30.63 million +1.5%N/A9.5 $1.72 8/15/202317,550,000 shares $28.61 million -2.2%N/A6.6 $1.63 7/31/202317,950,000 shares $36.08 million +14.2%N/A6.9 $2.01 7/15/202315,720,000 shares $34.74 million +8.7%N/A6.3 $2.21 6/30/202314,460,000 shares $33.11 million +38.0%N/A6.1 $2.29 6/15/202310,480,000 shares $26.93 million -2.6%N/A4.9 $2.57 5/31/202310,760,000 shares $35.51 million +66.8%N/A6.3 $3.30 5/15/20236,450,000 shares $19.22 million +30.8%N/A8.5 $2.98 4/30/20234,930,000 shares $11.78 million +17.4%N/A8.1 $2.39 4/15/20234,200,000 shares $10.12 million +3.5%N/A9.5 $2.41 3/31/20234,060,000 shares $9.87 million +2.3%N/A10.3 $2.43 3/15/20233,970,000 shares $9.09 million +4.2%N/A9.3 $2.29 2/28/20233,810,000 shares $8.57 million -8.0%N/A9.3 $2.25 2/15/20234,140,000 shares $9.44 million +3.5%N/A11.3 $2.28 1/31/20234,000,000 shares $8.96 million +2.6%N/A10.6 $2.24 1/15/20233,900,000 shares $9.20 million +0.3%N/A9.8 $2.36 12/30/20223,890,000 shares $7.43 million +2.9%N/A9.3 $1.91 12/15/20223,780,000 shares $8.05 million +0.3%N/A8.6 $2.13 11/30/20223,770,000 shares $8.07 million -2.3%N/A7.8 $2.14 11/15/20223,860,000 shares $8.96 million -9.4%N/A7.5 $2.32 10/31/20224,260,000 shares $9.16 million -4.7%N/A6.4 $2.15 10/15/20224,470,000 shares $9.43 million -0.2%N/A4.4 $2.11 9/30/20224,480,000 shares $10.75 million +11.4%N/A4.3 $2.40Are You Positioned For The New Energy Goldrush? (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. 9/15/20224,020,000 shares $10.77 million +7.8%N/A2.4 $2.68 8/31/20223,730,000 shares $10.26 million +1.9%N/A2.2 $2.75 8/15/20223,660,000 shares $12.55 million -55.2%N/A2.2 $3.43 7/31/20228,170,000 shares $19.44 million -0.9%N/A5.3 $2.38 7/15/20228,240,000 shares $25.38 million +6.6%8.0%6.9 $3.08 6/30/20227,730,000 shares $14.38 million +34.4%7.5%6.6 $1.86 6/15/20225,750,000 shares $8.05 million +5.7%5.6%10.5 $1.40 5/31/20225,440,000 shares $9.63 million +1.3%N/A10.9 $1.77 5/15/20225,370,000 shares $9.29 million +0.9%N/A8.8 $1.73 4/30/20225,320,000 shares $9.63 million +11.5%N/A8.4 $1.81 4/15/20224,770,000 shares $11.11 million +2.8%N/A7.3 $2.33 3/31/20224,640,000 shares $9.70 million -2.1%N/A7.1 $2.09 3/15/20224,740,000 shares $9.24 million -2.1%N/A6.8 $1.95 2/28/20224,840,000 shares $10.02 million +8.3%N/A6.8 $2.07 2/15/20224,470,000 shares $13.50 million +17.6%N/A7 $3.02 1/31/20223,800,000 shares $12.05 million +5.3%N/A5.9 $3.17 1/15/20223,610,000 shares $12.45 million +1.4%N/A5.6 $3.45 12/31/20213,560,000 shares $14.03 million +10.9%N/A5 $3.94 12/15/20213,210,000 shares $12.78 million -10.6%N/A4.3 $3.98 11/30/20213,590,000 shares $16.44 million -0.6%N/A4.9 $4.58 11/15/20213,610,000 shares $18.59 million +8.4%N/A4.1 $5.15 10/29/20213,330,000 shares $17.62 million -2.4%2.4%3.5 $5.29 10/15/20213,410,000 shares $21.01 million -2.9%2.4%3.6 $6.16 9/30/20213,510,000 shares $16.88 million -4.6%2.5%3.8 $4.81 9/15/20213,680,000 shares $16.71 million -11.1%2.6%3.4 $4.54 8/31/20214,140,000 shares $19.54 million +16.6%3.0%4 $4.72 8/13/20213,550,000 shares $12.89 million -8.5%2.5%4 $3.63 7/30/20213,880,000 shares $13.74 million -3.2%2.8%4.7 $3.54 7/15/20214,010,000 shares $14.80 million -8.2%2.9%4.9 $3.69 6/30/20214,370,000 shares $20.06 million +24.2%3.1%5.2 $4.59 6/15/20213,520,000 shares $16.68 million -3.3%2.5%5.3 $4.74 5/28/20213,640,000 shares $15.98 million -9.0%2.6%4.7 $4.39 5/14/20214,000,000 shares $16.80 million -5.7%N/A4.5 $4.20 4/30/20214,240,000 shares $21.37 million -5.4%N/A3.9 $5.04 4/15/20214,480,000 shares $23.25 million +20.1%N/A2.9 $5.19 3/31/20213,730,000 shares $21.15 million -24.0%N/A0.8 $5.67 3/15/20214,910,000 shares $33.73 million +36.8%N/A0.9 $6.87 2/26/20213,590,000 shares $26.85 million -20.0%N/A0.4 $7.48 2/12/20214,490,000 shares $35.96 million -16.2%N/A0.5 $8.01 1/29/20215,360,000 shares $43.20 million -52.9%N/A0.5 $8.06 1/15/202111,380,000 shares $91.61 million -5.1%N/A1 $8.05 12/31/202011,990,000 shares $39.69 million -2.0%N/A1.6 $3.31 12/15/202012,240,000 shares $36.48 million +29.0%N/A1.7 $2.98 11/30/20209,490,000 shares $15.37 million -1.7%N/A1.6 $1.62 11/15/20209,650,000 shares $12.26 million -0.4%N/A3.7 $1.27 10/30/20209,690,000 shares $11.24 million +3.1%N/A11.7 $1.16 10/15/20209,400,000 shares $13.63 million -7.2%9.1%7.7 $1.45 9/30/202010,130,000 shares $14.59 million -14.4%9.8%5.9 $1.44 9/15/202011,830,000 shares $18.81 million -13.0%11.5%7.1 $1.59 8/31/202013,590,000 shares $23.78 million -9.4%13.2%7.9 $1.75Are You Positioned For The New Energy Goldrush? (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. 8/14/202015,000,000 shares $27.15 million -8.9%14.5%8.6 $1.81 7/31/202016,460,000 shares $31.93 million +44.8%15.9%9.5 $1.94 7/15/202011,370,000 shares $22.29 million +9.3%11.0%8.2 $1.96 6/30/202010,400,000 shares $20.59 million -4.8%10.1%11.3 $1.98 6/15/202010,920,000 shares $20.64 million +8.6%10.6%11.7 $1.89 5/29/202010,060,000 shares $19.21 million -3.5%9.8%10.4 $1.91 5/15/202010,420,000 shares $19.59 million -0.7%10.1%10.8 $1.88 4/30/202010,490,000 shares $19.83 million -0.3%10.2%10.8 $1.89 4/15/202010,520,000 shares $21.25 million -5.9%10.2%11.1 $2.02 3/31/202011,180,000 shares $22.92 million -25.4%10.8%11.6 $2.05 3/13/202014,991,800 shares $28.18 million -9.5%14.6%14.5 $1.88 2/28/202016,570,000 shares $33.80 million +2.7%16.2%14.3 $2.04 2/14/202016,130,000 shares $37.10 million +3.2%15.7%12.7 $2.30 1/31/202015,630,000 shares $44.70 million +7.6%15.2%11.7 $2.86 1/15/202014,520,000 shares $46.75 million +6.9%14.1%10.5 $3.22 12/31/201913,580,000 shares $45.63 million +17.8%13.2%9.9 $3.36 8/15/20197,668,900 shares $10.20 million -17.4%7.5%7.1 $1.33 LXRX Short Interest - Frequently Asked Questions What is Lexicon Pharmaceuticals' current short interest? Short interest is the volume of Lexicon Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 23,270,000 shares of LXRX short. Learn More on Lexicon Pharmaceuticals' current short interest. What is a good short interest ratio for Lexicon Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LXRX shares currently have a short interest ratio of 6.0. Learn More on Lexicon Pharmaceuticals's short interest ratio. Is Lexicon Pharmaceuticals' short interest increasing or decreasing? Lexicon Pharmaceuticals saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 23,270,000 shares, a decline of 0.7% from the previous total of 23,440,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Lexicon Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Lexicon Pharmaceuticals: Rezolute, Inc. (0.77%), Ligand Pharmaceuticals Incorporated (4.77%), Dynavax Technologies Co. (17.34%), MannKind Co. (13.13%), BioCryst Pharmaceuticals, Inc. (16.64%), Innoviva, Inc. (18.86%), OPKO Health, Inc. (26.01%), Ironwood Pharmaceuticals, Inc. (14.52%), Vanda Pharmaceuticals Inc. (5.08%), XOMA Co. (2.09%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Lexicon Pharmaceuticals stock? Short selling LXRX is an investing strategy that aims to generate trading profit from Lexicon Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lexicon Pharmaceuticals? A short squeeze for Lexicon Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LXRX, which in turn drives the price of the stock up even further. How often is Lexicon Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LXRX, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: RZLT Short Interest Data LGND Short Interest Data DVAX Short Interest Data MNKD Short Interest Data BCRX Short Interest Data INVA Short Interest Data OPK Short Interest Data IRWD Short Interest Data VNDA Short Interest Data XOMA Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LXRX) was last updated on 6/3/2024 by MarketBeat.com Staff From Our PartnersThe Only Energy Play You Should Be Looking AtWealthpin Pro[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaBill Gates is all about this tiny $2 stockTimothy SykesMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceWhat’s Pelosi Buying Now?AltimetryHe Is Giving Away BitcoinCrypto Swap ProfitsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersWrite this ticker symbol down…StocksToTrade Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexicon Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.